Atlas Trials

Study of High-dose Influenza Vaccine Efficacy by Repeated Dosing IN Gammopathy Patients

Clinical trial NCT02566265 · COMPLETED

Trial details

NCT number
NCT02566265
Sponsor
Yale University
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
InfluenzaMultiple MyelomaWaldenstrom's MacroglobulinemiaPlasma Cell DisordersMGUS
Start date
2015-09-01
Primary completion
2017-10-01
Enrollment
122

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.